Research Institute:	GLAXO SMITHKLINE VACCINES
Callname:	GSK
Description:	GSK is a science-led global healthcare company with a mission: we want to help people to do more, feel better, live longer. On 2 March 2015 we completed a 3-part transaction with Novartis which reshapes our business. We acquired Novartiss vaccines business (excluding influenza vaccines) and combined our Consumer Healthcare businesses to create a new company. By substantially strengthening Vaccines and Consumer Healthcare, we can deliver far-reaching benefits to patients and consumers, and further value to shareholders. In addition, Novartis acquired our marketed Oncology portfolio. The vaccines, medicines and consumer healthcare products that we research and develop can improve peoples health and well-being, ultimately helping them to live life to its fullest and contribute to the prosperity of their communities. We ask each of our 8,000 employees working in Belgium to share our mission and to think about how they can help all those people who rely on our products. For that reason, every day our 1,800 scientists search for new ways to improve the treatment of diseases and illnesses. And that is why we have been pioneering new solutions allowing us to make our products available to those who need them, wherever they live and whatever their ability to pay.
Street + Number:	Rie de l institut 89
Postalcode + city:	1330 Rixensart
Country:	Belgium
Office Phone:	0032 10 85 85 00
Fax:
Email Address:
Website:	http://be.gsk.com/en/about-us/
Science Department:
Group Research Institute:
Division:
Rating:	1
ICT security industry:
ICT security intstitute:

Website